New Dupilumab Indication for Rare Skin Disease
- PMID: 36698357
- DOI: 10.1097/01.NAJ.0000919724.54645.7c
New Dupilumab Indication for Rare Skin Disease
Abstract
Dupilumab (Dupixent) has been approved for the treatment of prurigo nodularis, a rare skin disease.Nurses should teach patients how to administer the drug subcutaneously using the prefilled syringe and how to discard the used syringe.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
